We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$6.63B
AUM Growth
+$133M
(+2.1%)
Cap. Flow
+$377M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
12.08%
Holding
5,964
New
870
Increased
1,645
Reduced
2,091
Closed
1,097
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.5M |
| 2 |
WLL
Whiting Petroleum Corporation
WLL
|
+$10.4M |
| 3 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$8.32M |
| 4 |
Gilead Sciences
GILD
|
+$7.66M |
| 5 |
United States Oil Fund
USO
|
+$5.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$22.1M |
| 2 |
Kinder Morgan
KMI
|
+$16.3M |
| 3 |
AstraZeneca
AZN
|
+$11.7M |
| 4 |
TIBX
TIBCO SOFTWARE INC
TIBX
|
+$9.91M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$9.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.66% |
| 2 | Industrials | 2.15% |
| 3 | Technology | 2.02% |
| 4 | Energy | 1.33% |
| 5 | Consumer Discretionary | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
PUT
Smith & Nephew
SNN
$12.6B
| $173K | ﹤0.01% |
+4,700
| New | +$158K |
|
2302
PUT
Brookfield Infrastructure Partners
BIP
$18B
| $172K | ﹤0.01% |
10,332
+252
| +3% | +$4.02K |
|
2303
PUT
Live Nation Entertainment
LYV
$42.1B
| $172K | ﹤0.01% |
6,600
-1,700
| -20% | -$42.9K |
|
|
KITE
2304
DELISTED
Kite Pharma, Inc.
KITE
| $172K | ﹤0.01% |
+2,977
| New | +$125K |
|
|
RLYP
2305
DELISTED
RELYPSA INC COM
RLYP
| $172K | ﹤0.01% |
5,571
-19,538
| -78% | -$465K |
|
2306
Acadia Healthcare
ACHC
$2.94B
| $171K | ﹤0.01% |
2,794
+1,333
| +91% | +$77.6K |
|
2307
PUT
Danaher
DHR
$144B
| $171K | ﹤0.01% |
+2,976
| New | +$161K |
|
|
PGRE
2308
CALL
DELISTED
Paramount Group
PGRE
| $171K | ﹤0.01% |
+9,200
| New | +$169K |
|
|
DNR
2309
DELISTED
Denbury Resources, Inc.
DNR
| $171K | ﹤0.01% |
21,043
+7,419
| +54% | +$77K |
|
|
IPXL
2310
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
| $171K | ﹤0.01% |
5,400
-19,500
| -78% | -$571K |
|
|
PWE
2311
CALL
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $171K | ﹤0.01% |
82,300
+16,500
| +25% | +$65K |
|
|
QLGC
2312
PUT
DELISTED
QLOGIC CORP
QLGC
| $171K | ﹤0.01% |
12,800
+12,700
| +12,700% | +$145K |
|
2313
CALL
Chegg
CHGG
$102M
| $170K | ﹤0.01% |
24,600
-7,400
| -23% | -$47.9K |
|
2314
CALL
EyePoint Inc
EYPT
$1.2B
| $170K | ﹤0.01% |
4,130
-2,850
| -41% | -$114K |
|
2315
CALL
IMAX
IMAX
$2.66B
| $170K | ﹤0.01% |
5,500
-7,000
| -56% | -$205K |
|
2316
PUT
ON Semiconductor
ON
$31.6B
| $170K | ﹤0.01% |
16,800
-600
| -3% | -$5.27K |
|
2317
PUT
Puma Biotechnology
PBYI
$454M
| $170K | ﹤0.01% |
900
-6,100
| -87% | -$1.35M |
|
2318
PUT
Silicon Motion
SIMO
$8.68B
| $170K | ﹤0.01% |
7,200
+100
| +1% | +$2.4K |
|
|
WFT
2319
DELISTED
Weatherford International plc
WFT
| $170K | ﹤0.01% |
14,881
-24,145
| -62% | -$362K |
|
|
OKS
2320
DELISTED
Oneok Partners LP
OKS
| $170K | ﹤0.01% |
+4,301
| New | +$204K |
|
2321
Plains GP Holdings
PAGP
$4.9B
| $169K | ﹤0.01% |
+2,474
| New | +$176K |
|
|
SAND
2322
DELISTED
Sandstorm Gold
SAND
| $169K | ﹤0.01% |
49,819
-11,882
| -19% | -$39.4K |
|
2323
PUT
Tredegar Corp
TG
$310M
| $169K | ﹤0.01% |
7,500
+6,000
| +400% | +$113K |
|
|
RAI
2324
DELISTED
Reynolds American Inc
RAI
| $169K | ﹤0.01% |
+5,256
| New | +$166K |
|
2325
PUT
Medifast
MED
$141M
| $168K | ﹤0.01% |
5,000
| – | – |
|
Similar funds
SCP
Group One Trading's Q4 2014 Portfolio in Review
As of Q4 2014, Group One Trading held 5,964 positions worth $6.63B, up 2.1% from $6.49B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Group One Trading deployed $377M of net new capital in Q4 2014, opening 870 new positions and adding to 1,645 existing holdings. Its largest new stake was Whiting Petroleum Corporation: 684 shares worth $6.77M.
By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 2.8% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was AstraZeneca, an estimated $11.7M trimmed.
- Group One Trading's largest Q4 2014 buy was Whiting Petroleum Corporation: 684 shares worth $6.77M.
- Group One Trading added most to Allergan plc in Q4 2014, an estimated $18.5M increase.
- Group One Trading's biggest Q4 2014 reduction was AstraZeneca, cutting an estimated $11.7M.
- Group One Trading fully exited Herc Holdings in Q4 2014, selling an estimated $22.1M.
- Group One Trading's ten largest holdings make up 12% of its $6.63B portfolio in Q4 2014.
- Group One Trading opened 870 new positions and closed 1,097 in Q4 2014.
- Group One Trading's portfolio value rose 2.1% quarter-over-quarter to $6.63B.
Based on Group One Trading's 13F filing for Q4 2014, filed 11 Feb 2015.